Paradoxically, FGF-2 has been demonstrated to inhibit cellular proliferation and promote apoptosis in certain human breast cancer cell lines as well as being associated with good prognostic indicators when over expressed in some breast cancers [58]. This evidence concerns the gene FGF2 and breast carcinoma.